APA (7th ed.) Citation

Stertz, L., Di Re, J., Pei, G., Fries, G. R., Mendez, E., Li, S., . . . Walss-Bass, C. (2021). Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients. Neuropsychopharmacology (New York, N.Y.), 46(3), 673-682. https://doi.org/10.1038/s41386-020-00924-0

Chicago Style (17th ed.) Citation

Stertz, Laura, et al. "Convergent Genomic and Pharmacological Evidence of PI3K/GSK3 Signaling Alterations in Neurons from Schizophrenia Patients." Neuropsychopharmacology (New York, N.Y.) 46, no. 3 (2021): 673-682. https://doi.org/10.1038/s41386-020-00924-0.

MLA (9th ed.) Citation

Stertz, Laura, et al. "Convergent Genomic and Pharmacological Evidence of PI3K/GSK3 Signaling Alterations in Neurons from Schizophrenia Patients." Neuropsychopharmacology (New York, N.Y.), vol. 46, no. 3, 2021, pp. 673-682, https://doi.org/10.1038/s41386-020-00924-0.